Follow The Filings

OBIO Orchestra Biomed Holdings Inc.

Health Care, filed as ORCHESTRA BIOMED HOLDINGS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.1%
  • $547K

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel 0.10%

Who owns OBIO

Sorted by value, long equity only, as of 2026 Q2.

History
Nathan Fischel, Dafna Capital Management 0.10% Hold 126,841 $547K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by OBIO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OBIO insider trades
  • $280K bought by 4 insiders
  • $132 sold by 1 insider outside a trading plan
  • $353K sold by 1 insider under 10b5-1 plans
  1. Darren Sherman See Remarks
    Planned sale
    $95K 15,000 shares at $6.36 1.3% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  2. David P Hochman See Remarks
    Buy
    $48K 10,000 shares at $4.79 +0.9% to stake
    Traded Sep 3 Filed Sep 8
    ↗
  3. Darren Sherman See Remarks
    Planned sale
    $74K 15,000 shares at $4.94 1.3% of stake
    Traded Sep 1 Filed Sep 2
    ↗
  4. Darren Sherman See Remarks
    Buy
    $11K 2,000 shares at $5.33 New stake
    Traded Aug 26 Filed Aug 28
    ↗
  5. Darren Sherman See Remarks
    Planned sale
    $61K 15,000 shares at $4.09 1.3% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  6. Darren Sherman See Remarks
    Planned sale
    $64K 15,000 shares at $4.27 1.3% of stake
    Traded Jul 1 Filed Jul 2
    ↗
  7. David P Hochman See Remarks
    Buy
    $19K 5,000 shares at $3.83 +0.5% to stake
    Traded Jun 1 Filed Jun 2
    ↗
  8. Darren Sherman See Remarks
    Planned sale
    $58K 15,000 shares at $3.87 1.3% of stake
    Traded Jun 1 Filed Jun 2
    ↗
  9. Jason Aryeh Director
    Buy
    $2,494 665 shares at $3.75 +0.6% to stake
    Traded May 18 Filed May 20
    ↗
  10. Jason Aryeh Director
    Buy
    $35K 8,971 shares at $3.90 +8.3% to stake
    Traded May 15 Filed May 19
    ↗
  11. David P Hochman See Remarks
    Buy
    $19K 5,000 shares at $3.77 +0.5% to stake
    Traded May 15 Filed May 19
    ↗
  12. Eric S Fain Director
    Buy
    $83K 20,000 shares at $4.13 +28% to stake
    Traded May 14 Filed May 18
    ↗
  13. Rtw Investments, LP 10% owner, +1 joint filer
    Sale
    $132 32 shares at $4.13 <0.1% of stake
    Traded Apr 27 Filed Apr 29
    ↗
  14. David P Hochman See Remarks
    Buy
    $43K 10,000 shares at $4.29 +0.9% to stake
    Traded Mar 13 Filed Mar 16
    ↗
  15. David P Hochman See Remarks
    Buy
    $20K 5,000 shares at $4.07 +0.8% to stake
    Traded Nov 14, 2025 Filed Nov 17, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 32 share withholdings for taxes, 7 stock grants, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 9 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
DEFA14A Filing Doc
10-Q Filing Doc
DEF 14A FORM DEF 14A Filing Doc
SCHEDULE 13D/A — Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 14 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.76M $2.64M $33.48M
Gross profit * $2.57M $2.43M $33.29M
Gross margin * 93.3% 92.3% 99.4%
Net income -$49.12M -$61.02M -$52.7M
Net margin * -1779.7% -2313.3% -157.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $89.11M $69.17M $107.91M
Total non-current assets * $6.1M $7M $6.95M
Total assets $95.21M $76.17M $114.86M
Total current liabilities $11.21M $16.21M $16.74M
Total non-current liabilities * $15.96M $27.01M $34.74M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$46.13M -$50.56M -$48.96M
Cash from investing $10.69M $13.09M -$26.94M
Cash from financing $46.22M $29.17M $88.33M
Net change in cash $10.78M -$8.3M $12.43M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.